209 related articles for article (PubMed ID: 21732781)
1. Expression of AIF and HtrA2/Omi in small lymphocytic lymphoma and diffuse large B-cell lymphoma.
Li S; Wan M; Cao X; Ren Y
Arch Pathol Lab Med; 2011 Jul; 135(7):903-8. PubMed ID: 21732781
[TBL] [Abstract][Full Text] [Related]
2. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
Kempkensteffen C; Hinz S; Christoph F; Krause H; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
J Cancer Res Clin Oncol; 2008 May; 134(5):543-50. PubMed ID: 17922292
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer.
Lee SH; Lee JW; Kim HS; Kim SY; Park WS; Kim SH; Lee JY; Yoo NJ
APMIS; 2003 May; 111(5):586-90. PubMed ID: 12887511
[TBL] [Abstract][Full Text] [Related]
4. Variations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death : Omi/HtrA2 and aged heart injury.
Wang K; Zhang J; Liu J; Tian J; Wu Y; Wang X; Quan L; Xu H; Wang W; Liu H
Age (Dordr); 2013 Jun; 35(3):733-46. PubMed ID: 22535253
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization.
Arnoult D; Gaume B; Karbowski M; Sharpe JC; Cecconi F; Youle RJ
EMBO J; 2003 Sep; 22(17):4385-99. PubMed ID: 12941691
[TBL] [Abstract][Full Text] [Related]
6. Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy.
Wang P; Hu Y; Yao D; Li Y
Cell Physiol Biochem; 2018; 49(6):2163-2173. PubMed ID: 30286467
[TBL] [Abstract][Full Text] [Related]
7. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212.
Yang L; Sun M; Sun XM; Cheng GZ; Nicosia SV; Cheng JQ
J Biol Chem; 2007 Apr; 282(15):10981-7. PubMed ID: 17311912
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2.
Srinivasula SM; Gupta S; Datta P; Zhang Z; Hegde R; Cheong N; Fernandes-Alnemri T; Alnemri ES
J Biol Chem; 2003 Aug; 278(34):31469-72. PubMed ID: 12835328
[TBL] [Abstract][Full Text] [Related]
9. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis.
Yang QH; Church-Hajduk R; Ren J; Newton ML; Du C
Genes Dev; 2003 Jun; 17(12):1487-96. PubMed ID: 12815069
[TBL] [Abstract][Full Text] [Related]
10. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif.
Martins LM; Iaccarino I; Tenev T; Gschmeissner S; Totty NF; Lemoine NR; Savopoulos J; Gray CW; Creasy CL; Dingwall C; Downward J
J Biol Chem; 2002 Jan; 277(1):439-44. PubMed ID: 11602612
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of HTRA2/Omi is associated with infantile neurodegeneration and 3-methylglutaconic aciduria.
Mandel H; Saita S; Edvardson S; Jalas C; Shaag A; Goldsher D; Vlodavsky E; Langer T; Elpeleg O
J Med Genet; 2016 Oct; 53(10):690-6. PubMed ID: 27208207
[TBL] [Abstract][Full Text] [Related]
12. Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration.
Ding X; Patel M; Shen D; Herzlich AA; Cao X; Villasmil R; Klupsch K; Tuo J; Downward J; Chan CC
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4957-66. PubMed ID: 19443712
[TBL] [Abstract][Full Text] [Related]
13. Omi/HtrA2 and XIAP are components of platelet apoptosis signalling.
Winkler J; Rand ML; Schmugge M; Speer O
Thromb Haemost; 2013 Mar; 109(3):532-9. PubMed ID: 23306356
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice.
Martins LM; Morrison A; Klupsch K; Fedele V; Moisoi N; Teismann P; Abuin A; Grau E; Geppert M; Livi GP; Creasy CL; Martin A; Hargreaves I; Heales SJ; Okada H; Brandner S; Schulz JB; Mak T; Downward J
Mol Cell Biol; 2004 Nov; 24(22):9848-62. PubMed ID: 15509788
[TBL] [Abstract][Full Text] [Related]
15. THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death.
Balakrishnan MP; Cilenti L; Mashak Z; Popat P; Alnemri ES; Zervos AS
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H643-53. PubMed ID: 19502560
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2.
Cilenti L; Lee Y; Hess S; Srinivasula S; Park KM; Junqueira D; Davis H; Bonventre JV; Alnemri ES; Zervos AS
J Biol Chem; 2003 Mar; 278(13):11489-94. PubMed ID: 12529364
[TBL] [Abstract][Full Text] [Related]
17. Response of caspase-independent apoptotic factors to high salt diet-induced heart failure.
Siu PM; Bae S; Bodyak N; Rigor DL; Kang PM
J Mol Cell Cardiol; 2007 Mar; 42(3):678-86. PubMed ID: 17292393
[TBL] [Abstract][Full Text] [Related]
18. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction.
Hegde R; Srinivasula SM; Zhang Z; Wassell R; Mukattash R; Cilenti L; DuBois G; Lazebnik Y; Zervos AS; Fernandes-Alnemri T; Alnemri ES
J Biol Chem; 2002 Jan; 277(1):432-8. PubMed ID: 11606597
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
[TBL] [Abstract][Full Text] [Related]
20. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15.
Trencia A; Fiory F; Maitan MA; Vito P; Barbagallo AP; Perfetti A; Miele C; Ungaro P; Oriente F; Cilenti L; Zervos AS; Formisano P; Beguinot F
J Biol Chem; 2004 Nov; 279(45):46566-72. PubMed ID: 15328349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
